Login
$TXMD
$1.83 +$0.02 (1.08%) After hours

$TXMD 8-K/A SEC Filings

Filed On Filing
06 Jan 2023 8-K/A: Departure/Election of Directors or Officers; Compensation

Effective December 30, 2022 (the “Closing Date”), TherapeuticsMD, Inc., a Nevada corporation (the “Company”), completed its previously announced transaction (the “Transaction”) with Mayne Pharma LLC, a Delaware limited liability company ...

06 Jun 2022 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year

TherapeuticsMD, Inc., a Nevada corporation (the “Company”), desires to amend its Bylaws.

16 Nov 2021 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure

Rob Finizio; TherapeuticsMD, Inc.; Co-Founder, CEO & Director

03 Feb 2012 8-K/A: Changes in Registrant's Certifying Accountant

We were previously the independent accountants for VitaMedMD, LLC. (“VitaMed”) a wholly owned subsidiary of TherapeuticsMD, Inc. (the “Corporation”) and on July 15, 2011 we reported on the financial statements of VitaMed as of and for th...

02 Feb 2012 8-K/A: Financial Statements and Exhibits

This Financing Agreement (the “Agreement”) is between (i) Lang Naturals, Inc., a Rhode Island corporation, having its principal place of business at 20 Silva Lane, Middletown, RI 02842-7201 (“Lang”) and (ii) VitaMedMD, LLC, a Delaware li...

09 Dec 2011 8-K/A: Financial Statements and Exhibits

This Financing Agreement (the “Agreement”) is between (i) Lang Naturals, Inc., a Rhode Island corporation, having its principal place of business at 20 Silva Lane, Middletown, RI 02842-7201 (“Lang”) and (ii) VitaMedMD, LLC, a Delaware li...

08 Dec 2011 8-K/A: Financial Statements and Exhibits

See Financial Statements of VitaMed for six months ended June 30, 2011 and for years ended December 31, 2010 and 2009 filed as exhibits to the 14C filed with the Commission on September 12, 2011.

22 Nov 2011 8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more

This Security Agreement (as amended, modified or otherwise supplemented from time to time, this “Agreement”), dated as of July 18th, 2011, is executed by VitaMedMD, LLC, a Delaware limited liability company (together with its successors ...

15 Jun 2010 8-K/A: Financial Statements and Exhibits

Statements of Operations for the Period October 21, 2009 (Inception) through December 31, 2009

06 Oct 2009 8-K/A: Changes in Registrant's Certifying Accountant

On September 29, 2009 my appointment as auditor for AMHN, Inc. (formerly Croff Enterprises, Inc.) ceased. I have read AMHN, Inc.’s statements included under Item 4.01 of its Form 8-K/A dated October 6, 2009 and agree with such statements...

02 Jul 2008 8-K/A: Unregistered Sales of Equity Securities; Departure/Election of Directors or Officers; Compensation

DENVER, CO – 06/12/2008 -- Croff Enterprises, Inc. (OTCBB: COFF)announced today that the members of the Board of Directors including the Company’s Chairman and President have entered into agreements to sell all of their shares in Croff E...

13 Apr 2006 8-K/A: Changes in Registrant's Certifying Accountant

The undersigned Causey Demgen & Moore Inc. previously acted as the registered public accounting firm to audit the financial statements of Croff Enterprises, Inc. (the “Company”). We are no longer acting as the registered public accountin...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support